title: Critically evaluating adverse drug events retrospectively for research: is there a standard?
authors.affiliation: Center for Pharmacoinformatics and Outcomes Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. SLK54@pitt.edu
authors.forename: Sandra L
authors.initials: SL
authors.lastname: Kane-Gill
authors.forename: Desiree E
authors.initials: DE
authors.lastname: Kosmisky
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Dasta
authors.forename: Laura T
authors.initials: LT
authors.lastname: Pizzi
authors.forename: Richard
authors.initials: R
authors.lastname: Toner
authors.forename: Kathleen
authors.initials: K
authors.lastname: Foley
authors.forename: Erin
authors.initials: E
authors.lastname: Thomson
authors.forename: Wing
authors.initials: W
authors.lastname: Chow
authors.forename: Myoung
authors.initials: M
authors.lastname: Kim
authors.forename: Joseph
authors.initials: J
authors.lastname: Couto
authors.forename: Marc
authors.initials: M
authors.lastname: Royo
authors.forename: Eugene
authors.initials: E
authors.lastname: Viscusi
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007902:Length of Stay / Q000639:trends*; D008297:Male; D019637:Orthopedic Procedures
chemical_list: D000701:Analgesics, Opioid